The numbers
Boeing’s stock is currently priced at US$195.12, reflecting a troubling 7% decline over the past week. This downturn follows a 15.9% decline over the last month, raising concerns among investors about the company’s recovery trajectory.
Despite these setbacks, Boeing has managed to achieve a 9.6% gain over the past year, indicating some resilience in its performance. However, the latest twelve-month free cash flow shows a significant loss of approximately $1.57 billion, which underscores ongoing financial challenges.
Looking ahead, Boeing’s projected free cash flow is expected to improve, with estimates of $2.14 billion in 2026 and reaching $13.60 billion by 2030. These projections are crucial as the company aims to stabilize its finances and regain investor confidence.
Analysts have noted that Boeing’s estimated intrinsic value stands at about $320.29 per share, suggesting that the stock is currently 39.1% undervalued. This valuation could present a buying opportunity for investors willing to take a risk on the stock’s recovery.
In terms of financial metrics, Boeing currently trades on a price-to-earnings (P/E) ratio of 81.17x, which is significantly above the Aerospace & Defense industry average of 40.33x. This elevated P/E ratio may indicate that investors are pricing in future growth, despite the current cash flow issues.
Boeing’s Q4 revenue was reported at $23.95 billion, marking a substantial 57% increase year-over-year. This revenue growth is a positive sign, but it is tempered by the company’s ongoing struggles with cash flow and a consolidated debt of $54.1 billion.
CEO Kelly Ortberg remarked, “We made significant progress on our recovery in 2025 and have set the foundation to keep our momentum going in the year ahead.” This statement reflects the company’s commitment to overcoming its financial hurdles and stabilizing its operations.
As Boeing navigates these challenges, observers are keenly watching for signs of improvement in cash flow and overall financial health. Details remain unconfirmed regarding the timeline for recovery, but the company’s projections and recent revenue growth offer a glimmer of hope for investors.
